The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Lorillard Calls on Tobacco Committee to Assess Menthol With Dispassionate, Data-Driven Science

Friday, July 16, 2010

Lorillard Calls on Tobacco Committee to Assess Menthol With Dispassionate, Data-Driven Science14:48 EDT Friday, July 16, 2010Data is Overwhelming and ConsistentGREENSBORO, N.C., July 16 /PRNewswire-FirstCall/ -- With the words of Food and Drug Commissioner Margaret Hamburg on the screen beside him, a Lorillard Tobacco Company (NYSE: LO) scientist today called upon the FDA's Tobacco Products Scientific Advisory Committee (TPSAC) to employ a "truly science-based, data-driven" process in its evaluation of menthol in cigarettes. �Earlier this week Hamburg made headlines when she told an FDA science panel to "Follow the science wherever it leads and the rest will fall into place.""The data is overwhelming and consistent ? menthol has no effect on the health risks of smoking," Dr. William R. True, senior vice president, research and development, said in a presentation at the conclusion of two days of committee hearings. The process of evaluating the health effects of menthol "seems to have begun with an underlying presumption by several Committee members that menthol must have some adverse effect and, despite all the evidence to the contrary, the Committee members keep searching for some data that might support their presumption," �True said."Science has to be dispassionate," he said. �"When the data doesn't support the hypothesis, the hypothesis must be abandoned. �That is the scientific method; that is sound science."Legislation signed into law last year authorized the Food and Drug Administration (FDA) to regulate cigarettes and other tobacco products. One provision of the law mandated the creation of TPSAC, which will submit a report and recommendation on the use of menthol in cigarettes to the FDA.The full statement as delivered by Dr. True:"Extensive and conclusive data on the health effects of menthol in cigarettes already exists. �The major manufacturers have done their best to provide the information requested by the Committee, not only through the presentations over the past two days, but also with hundreds and perhaps thousands of pages of submissions and extensive bibliographies of relevant published studies."In addition, an extensive document production has already been made to FDA ? and another will be made in August ? and all the detailed product information has been provided to the FDA."The Committee says it needs more data."Thirteen epidemiology studies ? the gold standard of evaluating disease risk. �"The largest cigarette biomarker study ever conducted ? Phillip Morris' study with 3,600 smokers, over ten times the number of smokers in any study."Three of the four national surveys show no effect of menthol on initiation, dependence or cessation."The data is overwhelming and consistent ? menthol has no effect on the health risks of smoking. �"Or, is the Committee adopting a standard that requires more than thirteen epidemiology studies and biomarkers studies of more than 3,600 participants to come to any conclusion on any health issue related to cigarettes?"The process of evaluating the health effects of menthol seems to have begun with an underlying presumption by several Committee members that menthol must have some adverse effect and, despite all of the evidence to the contrary, these Committee members keep searching for some data that might support their presumption."The undercurrent of this notion appears to be preventing this evaluation process from being truly science-based and data-driven. �Science has to be dispassionate. �When the data doesn't support the hypothesis, the hypothesis must be abandoned. �That is the scientific method; that is sound science."About Lorillard, Inc. Lorillard, Inc. (NYSE: LO) is the third largest manufacturer of cigarettes in the United States. Founded in 1760, Lorillard is the oldest continuously operating tobacco company in the U.S. Newport, Lorillard's flagship menthol-flavored premium cigarette brand, is the top selling menthol and second largest selling cigarette in the U.S. In addition to Newport, the Lorillard product line has five additional brand families marketed under the Kent, True, Maverick, Old Gold and Max brand names. These six brands include 41 different product offerings which vary in price, taste, flavor, length and packaging. Lorillard maintains its headquarters and manufactures all of its products in Greensboro, North Carolina.Forward-Looking StatementsCertain statements made in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, or the Reform Act. Forward-looking statements include, without limitation, any statement that may project, indicate or imply future results, events, performance or achievements, and may contain the words "expect," "intend," "plan," "anticipate," "estimate," "believe," "may," "will be," "will continue," "will likely result" and similar expressions. In addition, any statement that may be provided by management concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects and possible actions by Lorillard, Inc. are also forward-looking statements as defined by the Reform Act.Forward-looking statements are based on current expectations and projections about future events and are inherently subject to a variety of risks and uncertainties, many of which are beyond our control, that could cause actual results to differ materially from those anticipated or projected. Information describing factors that could cause actual results to differ materially from those in forward-looking statements is available in Lorillard, Inc.'s filings with the Securities and Exchange Commission (the "SEC"), including but not limited to, our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. These filings are available from the SEC over the Internet or in hard copy, and are available on our website at www.lorillard.com. Forward-looking statements speak only as of the time they are made, and we expressly disclaim any obligation or undertaking to update these statements to reflect any change in expectations or beliefs or any change in events, conditions or circumstances on which any forward-looking statement is based.CONTACT: Gregg Perry(401) 886-7200gperry@perrypublicrelations.com SOURCE Lorillard, Inc.For further information: Gregg Perry, +1-401-886-7200, gperry@perrypublicrelations.com